foxo4 dri peptide senolytic 2023 FOXO4-DRI Research – 15mg FOXO4-DRI - Beverly Hills Rejuvenation
FOXO4 DRI Beverly Hills Rejuvenation Center FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology
Pay in 4 interest-free payments of $6.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25



